MarkAlanMcCurdyMD

Urology • Arlington, TX

Physician

Join to view full profile

Dr. McCurdy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McCurdy's full profile

Already have an account?

Office
811 W Interstate 20
Ste 114
Arlington, TX 76017
Phone+1 817-784-8268

Fax+1 817-804-8178

Education & Training

Baylor College of MedicineResidency, Urology, 1996 - 2000
Methodist Hospital (Houston)Residency, Surgery, 1994 - 1996
Baylor College of MedicineClass of 1994

Certifications & Licensure

TX State Medical License 1996 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

311 citations
ELEVATED LEVELS OF CIRCULATING INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-beta 1 IN PATIENTS WITH METASTATIC PROSTATIC CARCINOMA
Howard L. Adler, Mark A. McCurdy, Michael W. Kattan, Terry L. Timme, Peter T. Scardino
The Journal of Urology. 1999-01-01
138 citations
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Yasutomo Nasu, Chris H. Bangma, Gerald W. Hull, Hon-Man Lee, J. Hu
Gene Therapy. 1999-03-01
28 citations
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
Yasutomo Nasu, Chris H. Bangma, Gerald W. Hull, Guang Yang, Jianxiang Wang
Prostate Cancer and Prostatic Diseases. 2001-01-01